College of Psychiatric and Neurologic Pharmacists

Academia and Psychiatry/Neurology

Kelly Gable, PharmD, BCPP, Assistant Professor, Southern Illinois University Edwardsville School of Pharmacy and Thea Moore, PharmD, BCPP, Associate Professor, University of South Florida

This roundtable discussion will focus on networking with other faculty and developing qualities necessary to become a successful faculty member specializing in psychiatry/neurology. Discussion will involve balancing time between scholarship, teaching, and service in an effort to successfully move up the promotion and/or tenure track. Discussion items may include the following: preparing for annual and midpoint evaluations, beginning a successful scholarly program, making time for publications, developing a psychiatry/neurology syllabus and psychiatry-focused elective, and developing a successful clinical practice site that promotes interdisciplinary education. Academic discussions will be modified to best meet the needs of the roundtable audience.

Advocating for Pharmacist Reimbursement at the State Level

Discussion Topics:

1. Share successful payment models for pharmacist services at the state level.
2. Discuss options for developing support for pharmacist services at the state level.

• Identify the service for which you seek reimbursement
• Identify stakeholders and funding opportunities
• Develop a consistent message designed for the correct target audience
• Design supporting documentation

Canadian Pharmacists

Beth Sproule, PharmD, Clinician Scientist, Center for Addiction and Mental Health & Director, Division of Pharmacy Practice, Leslie Dan Faculty of Pharmacy, University of Toronto

This roundtable discussion will focus on networking with other Canadian psychiatric pharmacists, or those interested in practice in Canada.

Discussion Topics:

1. Psychiatric practice settings and opportunities in Canada.
2. Postgraduate training and continuing education opportunities in psychiatric pharmacy in Canada.
3. Establishing collaborative research initiatives in mental health practice.
4. The Canadian Association of Psychiatric Pharmacists activities and objectives.

BCPP Certification and Recertification

Bill Ellis, MS, BPS Executive Director and Cynthia Kirkwood, PharmD, BCPP, CPNP BCPP Program Director, Professor-Vice Chair for Education, Virginia Commonwealth University

This roundtable will address your BCPP certification and recertification questions. For those preparing for the initial BCPP exam and those recertifying by exam, Bill Ellis of BPS will be available to address criteria/requirements, preparing for the exam and what to expect when testing. Cindy Kirkwood, CPNP’s Recertification Program Director will be on hand to describe the BCPP review and recertification products available from CPNP for BCPP examination preparation and recertification, the recertifiation product examinations, CPNP transcript service, ACPE credit, and how to meet the required hours for recertification every 7 years.

FDA Safety Alerts: Getting the response right!

Sheila Botts, PharmD, FCCP, BCPP; Daniel Dugan, PharmD, BCPP, Kaiser-Permanente-Colorado

Several FDA safety alerts concerning psychiatric and neurologic medications have been issued in the recent past. These alerts often are delivered with little accompanying data, but include language that describes potentially significant risks for exposed patients. Health care organizations and individual practices are left to construct a response that is in the best interest of delivering safe care to the patient, while effectively using available resources. The roundtable will discuss the experiences and strategies of participants and seek best practices in response to recent FDA safety alerts (e.g. citalopram and dose dependent QT prolongation; ECG monitoring with stimulant medications, fingolimod and risk of death).

Discussion Topics:

1. How did you decide on an appropriate level of response to the alert-(dissemination of information, systematic reviews of at-risk patients, policy changes)
2. Who was invited to the table to formulate your response? What committee structure has your institution utilized?
3. Do you think it’s safe to “not respond”
4. What if you don’t have an EMR?
5. What’s was the role of clinical pharmacy specialists in your response?

Patient Medication Education Groups

J. Daniel Justino, PharmD, BCPP, Clinical Specialist in Psychiatry, Bay Pines VAHCS and Amy Werremeyer, PharmD, BCPP, Assistant Professor/Clinical Specialist in Psychiatry, North Dakota State University

This roundtable discussion will center on delivery of patient medication education groups in mental health treatment settings.

Objectives/Discussion Topics: The objective of this session will be to discuss philosophies, approaches, benefits, and common problems of patient medication education groups. The facilitators will promote discussion among the attendees regarding:

1. Why might medication education groups be beneficial for patients?
2. Why might pharmacists be the best-positioned members of the healthcare team to facilitate such groups?
3. How can patients be empowered to discuss their illness(es) and their treatment(s) in a health-promoting way?
4. How can group dynamics be utilized to promote healthy discussion and feedback among group members?
5. What topics might be considered for discussion in a medication education group?
6. What documentation may be important for pharmacists when facilitating medication education groups?

Veteran Affairs Pharmacists

Jennifer Bean, PharmD, BCPS, Clinical Pharmacy Specialist, VA-Tennessee Valley Healthcare System and Jennifer Zacher, PharmD, BCPP, Assistant Division Officer-Pharmacy Division, Captain James A. Lovell Federal Health Care Center

This roundtable is designed to provide a forum to discuss topics unique to pharmacists working within the Department of Veterans Affairs. We will be discussing a wide range of topics both administrative and clinical that can impact your practice site. This will be an opportunity learn how other VISN's and individual hospitals handle policy issues in regard to patient care, formulary, regulatory, university affiliation and continuing education issues.

Discussion Topics:

1. Handling of high risk suicide patients- limiting medication quantities
2. PGY-2 Psych residents and their inability to find jobs
3. Ideas for how to provide educational opportunities with limited time
4. Open Discussion